Search - tctmd.com

Displaying 381 - 400 of 532

Sort: Relevancy | Date

Presentation TCT 2018

TCT-6: The CENTER-Collaboration: Outcomes in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation With Balloon-Expandable Valves versus Self-Expandable Valves.

Presenter: Steven R. Bailey, Patrick W. Serruys, Ronak Delewi

September 22, 2018

Presentation TCT 2018

TCT-5: Long-term Preclinical in Vivo Results With a Restorative Aortic Valve

Presenter: Steven R. Bailey, Patrick W. Serruys, Christian M. Spaulding

September 22, 2018

Presentation TCT 2018

TCT-4: Reduction of Stroke With Use of the Double-Filter Cerebral Embolic Protection Device in Patients Undergoing Transfemoral Aortic Valve Replacement With Self-Expandable, Mechanically Implantable And Balloon-Expandable Aortic Valves

Presenter: Steven R. Bailey, Patrick W. Serruys, Julia Seeger

September 22, 2018

Presentation TCT 2018

TCT-3: The Lutonix® Global Drug Coated Balloon Registry Real World Patients With Below the Knee Disease Interim 12 Month Outcomes

Presenter: Steven R. Bailey, Patrick W. Serruys, Steve Henao

September 22, 2018

Presentation TCT 2018

TCT-2: DeepIVUS: A Machine Learning Framework for Fully Automatic IVUS Segmentation

Presenter: Steven R. Bailey, Patrick W. Serruys, David Molony

September 22, 2018

Presentation TCT 2018

TCT-1: Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

Presenter: Steven R. Bailey, Patrick W. Serruys, Sorin J. Brener

September 22, 2018

Presentation TCT 2018

The Methods for Coronary Stent Development

Presenter: Mitchell W. Krucoff, Gregg W. Stone, Donald Cutlip

September 21, 2018

Presentation TCT 2018

The Methods for Coronary Stent Development

Presenter: Mitchell W. Krucoff, Gregg W. Stone, Chuck Simonton

September 21, 2018

Presentation TCT 2018

The Endpoints for Translational Mitral/Tricuspid Valve Development

Presenter: Robert O. Bonow, John C Laschinger, Blase A. Carabello

September 21, 2018

Presentation TCT 2018

The Methods for Translational Mitral/Tricuspid Valve Development

Presenter: Robert O. Bonow, John C Laschinger, Michael J. Mack

September 21, 2018

Presentation TCT 2018

The Endpoints for Aortic Valve Development

Presenter: Jeroen J. Bax, Martin B. Leon, Ori Ben-Yehuda

September 21, 2018

Presentation TCT 2018

The TAVR Development from First in Man to Phase 3 and Beyond

Presenter: Robert O. Bonow, Stan Rowe, Martin B. Leon

September 21, 2018

Presentation TCT 2018

The TAVR Development from Concept to First in Man

Presenter: Robert O. Bonow, Stan Rowe, Alain G. Cribier

September 21, 2018

Presentation TCT 2018

Early Feasibility Studies for Device Evaluation

Presenter: Spencer B. King III, Bram D. Zuckerman, Andrew Farb

September 21, 2018

Presentation TCT 2018

Pre-Clinical and Clinical Trial Design and Endpoints for Device Approval

Presenter: Spencer B. King III, Bram D. Zuckerman, Chris Mullin, Roseann M White

September 21, 2018

Presentation TCT 2018

Practice Guideline Requirement for New Technology

Presenter: Spencer B. King III, Bram D. Zuckerman, Alice K. Jacobs

September 21, 2018

Presentation TCT 2018

CMS Requirement for Reimbursement for Innovation

Presenter: Spencer B. King III, Bram D. Zuckerman, Lori M Ashby

September 21, 2018

Presentation TCT 2018

Regulatory Requirement for Marketing Approval including the Parallel Review, NEST, and Beyond

Presenter: Spencer B. King III, Bram D. Zuckerman

September 21, 2018

Presentation TCT 2018

ISCTR Mission and Statement of Meeting Purpose

Presenter: Nabil Dib

September 21, 2018

Presentation The Structural Heart Disease Summit 2018

The Goal of FMR Treatment: Reduction or Elimination of MR?

Presenter: Randall C. Starling

June 21, 2018

Advertisement

TCT-6: The CENTER-Collaboration: Outcomes in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation With Balloon-Expandable Valves versus Self-Expandable Valves.

TCT-5: Long-term Preclinical in Vivo Results With a Restorative Aortic Valve

TCT-4: Reduction of Stroke With Use of the Double-Filter Cerebral Embolic Protection Device in Patients Undergoing Transfemoral Aortic Valve Replacement With Self-Expandable, Mechanically Implantable And Balloon-Expandable Aortic Valves

TCT-3: The Lutonix® Global Drug Coated Balloon Registry Real World Patients With Below the Knee Disease Interim 12 Month Outcomes

TCT-2: DeepIVUS: A Machine Learning Framework for Fully Automatic IVUS Segmentation

TCT-1: Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

The Methods for Coronary Stent Development

The Methods for Coronary Stent Development

The Endpoints for Translational Mitral/Tricuspid Valve Development

The Methods for Translational Mitral/Tricuspid Valve Development

The Endpoints for Aortic Valve Development

The TAVR Development from First in Man to Phase 3 and Beyond

The TAVR Development from Concept to First in Man

Early Feasibility Studies for Device Evaluation

Pre-Clinical and Clinical Trial Design and Endpoints for Device Approval

Practice Guideline Requirement for New Technology

CMS Requirement for Reimbursement for Innovation

Regulatory Requirement for Marketing Approval including the Parallel Review, NEST, and Beyond

ISCTR Mission and Statement of Meeting Purpose

The Goal of FMR Treatment: Reduction or Elimination of MR?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content